MegaCor Handel mit Medizintechnik und Diagnostik GmbH

Medical Technology · Lindau Bodensee

MegaCor Handel mit Medizintechnik und Diagnostik GmbH is a medical technology company based in Lindau Bodensee, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

MegaCor Handel mit Medizintechnik und Diagnostik GmbH Address & Contact

Website

Address

Europaplatz 1
88131 Lindau Bodensee

MegaCor Trade in Medical Technology and Diagnostics Ltd Overview

MegaCor Trade in Medical Technology and Diagnostics Ltd is a wholesale and foreign trader of medical technology products and in-vitro diagnostics from Lindau on Lake Constance in Baden-Württemberg. The company imports and distributes medical devices and diagnostics from Europe and overseas for the German and European market. Founded with the goal of bringing high-quality products to the healthcare sector, MegaCor has quickly established itself as a reliable partner in the industry.

Services and Products

The portfolio of MegaCor includes a wide range of medical technology devices used in various specialized areas. These include:

  • Diagnostic Devices: Devices for the early detection of diseases and to support diagnostic processes in hospitals and medical practices.
  • Laboratory Analytics: High-quality products for the analysis and evaluation of laboratory samples, used by both research institutions and clinical laboratories.
  • Patient Monitoring: Systems and devices for the continuous monitoring of vital parameters, critical for effective patient care.
  • In-vitro Diagnostics: A variety of tests and kits used in clinical laboratories for sample examination.

MegaCor coordinates the import, approval, and distribution of medical products and supports foreign manufacturers in entering the German and European markets. The company ensures that all products comply with the strict requirements of the European Medical Device Regulation, including the necessary CE marking. This not only guarantees the safety and efficacy of the products but also their compliance with current regulatory standards.

Regulatory Classification and Quality Assurance

The regulatory classification of products plays a central role for MegaCor. Through close cooperation with various health authorities and experts, the company is in constant communication to ensure that the products offered comply with applicable guidelines. MegaCor has implemented an internal quality assurance system that includes continuous training and regular inspections to ensure that the products not only meet legal requirements but also fulfill the high-quality standards of customers.

Location Lindau Bodensee / Baden-Württemberg

Lindau is located at the tri-border region of Germany-Austria-Switzerland on Lake Constance and offers ideal conditions for international medical technology trade as a border region site. The location allows for efficient coordination of import and export transactions in the Lake Constance region and throughout the DACH area. Furthermore, Lindau is known for its highly qualified specialists and favorable logistics connections, enabling MegaCor to respond quickly to market changes and ensure timely delivery to customers.

Regional Importance and Network

MegaCor has established itself in the region not only as a sales company but also as an important business partner and employer. By creating jobs and supporting local initiatives, the company contributes to the economic stability in Lindau. Additionally, MegaCor is actively engaged in networks and associations within the medical technology industry, promoting exchange with other companies and institutions and driving innovative developments forward.

Further medical technology companies: Medical Technology Overview | Medical Technology Baden-Württemberg | Laboratories

Frequently asked questions about MegaCor Handel mit Medizintechnik und Diagnostik GmbH

What does MegaCor Handel mit Medizintechnik und Diagnostik GmbH do?

MegaCor Handel mit Medizintechnik und Diagnostik GmbH is a company in the medical technology sector based in Lindau Bodensee. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.

Where is MegaCor Handel mit Medizintechnik und Diagnostik GmbH located?

MegaCor Handel mit Medizintechnik und Diagnostik GmbH is headquartered in Lindau Bodensee. More information can be found on the company's website.

In which area of medical technology is MegaCor Handel mit Medizintechnik und Diagnostik GmbH active?

MegaCor Handel mit Medizintechnik und Diagnostik GmbH is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.

Profile incomplete 🌐 Website

About Medical Technology

Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.

Germany as a Global Medical Technology Hub

Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.

EU MDR Compliance and CE Marking for German Manufacturers

The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.

Innovation and Research in German Medtech

Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.

Innovation Fields and Future Technologies

The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.

What does the medical technology sector cover?

Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.

How are medical devices approved in Germany?

Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.

Where can I find medical technology companies in Germany?

Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.

How many medical technology companies are there in Germany?

Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.

What are the risk classes for medical devices under the EU MDR?

The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.

Where are the main medical technology clusters in Germany?

Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.

What is a Notified Body (benannte Stelle) and why does it matter?

A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.

Last updated: 17.04.2026 · Category: Medical Technology